Cutaneous Leishmaniasis "Chiclero Ulcer" in the Amazon, Ecuador
Abstract
Leishmaniasis are diseases that affect the skin, mucosa and viscera, caused by the protozoan Leishmania, transmitted by the bite of phlebotomine insects. Cutaneous leishmaniasis and its clinical variants are prevalent in tropical and subtropical regions of Ecuador, in the Amazon, Costa and inter-Andean valleys. We present the case of a 27-year-old military man, with 3 months of evolution of 2 ulcerative lesions in the right forearm and in the hélix of the left ear, this last one called “chiclero ulcer”, infected in Shell Mera-Pastaza, Amazon. The parasitological diagnosis was by microscopic observation of the amastigotes in smears obtained from the lesions. Treated with meglumine antimoniate (Glucantime® 20 mg / kg body weight for 30 days, intramuscularly), having a favorable evolution and clinical cure 3 months after treatment. The blood chemistry and EKG studies before and after treatment showed no alterations or reported adverse effects to the drug.
Downloads
References
1. Calvopiña M, Armijos RX, Hashiguchi Y. Epidemiology of Leishmaniasis in Ecuador: Current Status of Knowledge – A Review. Mem Inst Oswaldo Cruz 2004, 99:663-672.
2. PAHO.https://www.paho.org/hq/index.php?option=com_content&view=article&id=6417:2012-leishmaniasis-cutanea-mucosa&Itemid=39345&lang=es).
3. Calvopiña M, Loor R, Lara F, Zambrano P, Hashiguchi Y. Prevalencia y formas clínicas de las leishmaniasis en el noroccidente de la provincia de Pichincha −Ecuador. Rev Fac Cienc Med (Quito). 2012: 37, 31–38.
4. Calvopina M, Martínez L, Yoshihisa H. Cutaneous Leishmaniasis “Chiclero’s Ulcer” in Subtropical Ecuador. Am J Trop Med Hyg. 2013; 89(2): 195–196 doi:10.4269/ajtmh.12-0690
5. Ministerio de Salud Pública. SIVE-ALERTA(2012), 2012. Casos de Leishmaniasis reportados en Ecuador 2011-2012. Ecuador.
6. Ministerio de Salud Pública. Manual de normas técnicas para la prevención, manejo y control de la leishmaniasis tegumentaria en el Ecuador. (2011), pp. 1-41.
7. WHO, Control of the leishmaniases. WHO Technical Report Series 949. Report of a meeting of the WHO Expert Committee on the Control of Leishmaniases, Geneva, 22–26 March 2010.
8. Armijos RX, Weigel MM, Calvopiña M, Mancheno M, Rodriguez R, Veletanga J. Comparison of the effectiveness of two topical paromomycin treatments versus meglumine antimoniate for New World cutaneous leishmaniasis. Acta Tropica. 2014; 91: 153–160
9. Weigel MM, Armijos RX. The traditional and conventional medical treatment of cutaneous leishmaniasis in rural Ecuador. Rev Panam Salud Publica/Pan Am J Public Health 2001;10(6):395-404.
10. Kato H, Calvopiña M, Criollo H, Hashiguchi Y. First human cases of Leishmania (Viannia) naiffi infection in Ecuador and identification of its suspected vector species. Acta Tropica 2013; 128: 710-713.
11. Kato H, Gomez EA, Seki C, Furumoto H, Martini-Robles L, Muzzio J, Calvopiña M, Velez L, Kubo M, Tabbabi A, Yamamoto DS, Hashiguchi Y. PCR-RFLP analyses of Leishmania species causing cutaneous and mucocutaneous leishmaniasis revealed distribution of genetically complex strains with hybrid and mito-nuclear discordance in Ecuador. PLoS Negl Trop Dis. 2019;13(5): e0007403. https://doi. org/10.1371/journal.pntd.0007403
Copyright (c) 2020 Rural Family Practice
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
